Aspirin Resistance in Systemic Lupus Erythematosus (SLE)
Status:
Completed
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
This study examine whether patients with lupus respond to aspirin , and if not, if that is
related to inflammation. We examine the ability of aspirin to inhibit the production of
thromboxane in patients with lupus and controls and see if aspirin insensitive thromboxane
production is inhibited by meloxicam.
Phase:
Phase 1
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center